# Asan Foundation

> Asan Foundation is a VC fund in Seoul backing Biotechnology, Medical and Genetics. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Seoul, South Korea
- Total investments: 4
- Last investment: Dec 2024
- Lead investor: 0%
- Last updated: Aug 2026
- Website: https://www.asanfoundation.or.kr

Asan Foundation is a social organization that provides social, counselling, welfare, and medical services to people with families.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 50% |
| Medical | 1 | 25% |
| Genetics | 1 | 25% |
| Software | 1 | 25% |
| Biopharma | 1 | 25% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 3 | 75% |
| Venture - Series Unknown | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 2 | 50% |
| United States | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Inocras | Inocras Inc. specializes in whole genome sequencing and analytics, focusing on providing insights for personalized care in cancer and rare diseases. Utilizing artificial intelligence, Inocras aims to revolutionize healthcare by enabling precision medicine. The company offers services to patients, healthcare providers, researchers, and partners,seeking to unlock new possibilities in precision health. With a commitment to innovation, Inocras has introduced products like CancerVision and RareVision, designed to enhance diagnosis and treatment strategies through comprehensive genomic analysis. |  | Venture - Series Unknown | Dec 05, 2024 |  |
| Inocras | Inocras Inc. specializes in whole genome sequencing and analytics, focusing on providing insights for personalized care in cancer and rare diseases. Utilizing artificial intelligence, Inocras aims to revolutionize healthcare by enabling precision medicine. The company offers services to patients, healthcare providers, researchers, and partners,seeking to unlock new possibilities in precision health. With a commitment to innovation, Inocras has introduced products like CancerVision and RareVision, designed to enhance diagnosis and treatment strategies through comprehensive genomic analysis. | $23M | Series B | Nov 01, 2023 |  |
| Organoid Sciences | Organoid Sciences is an organoid-based treatment drug development company that offers drug screening and regenerative medicines. | $15.1M | Series B | Nov 22, 2021 |  |
| Cenacle | Cenacle Soft is a provider of cloud-based healthcare technologies that aim to improve the patient experience. Through an interlocking system, the company's technologies create a suitable environment for doctors without the need for external programs, allowing hospitals to support their work anytime, anywhere, regardless of time or place. | $10.9M | Series B | Jul 26, 2021 |  |

4 of 4 investments shown.

## Co-investors
- [Ignite Innovation Fund](https://shizune.co/investors/profile/ignite-innovation-fund) — VC Fund, 2 deals together
- [Samsung Venture Investment](https://shizune.co/investors/profile/samsung-venture-investment-705d) — VC Fund, 2 deals together
- [Big Move Ventures](https://shizune.co/investors/profile/big-move-ventures) — VC Fund, 1 deal together
- Dongwha Pharm — VC Fund, 1 deal together
- [Dunamu & Partners](https://shizune.co/investors/profile/dunamu-partners) — VC Fund, 1 deal together
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Asan Foundation invest in?

Asan Foundation invests primarily in Biotechnology, Medical and Genetics startups, most often at Series B and Venture - Series Unknown stage. Most of the 4 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Asan Foundation last invest?

The most recent investment recorded for Asan Foundation closed in Dec 2024. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co